Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome
JAMA Dermatol 2020 Dec 30;[EPub Ahead of Print], DJ Lewis, PL Haun, SS Samimi, CC Vittorio, J Villasenor-Park, SK Barta, DJ Landsburg, J Svoboda, SD Nasta, SJ Schuster, AH Rook, EJ KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.